meta_analysis
    2008
    High Quality

    Vinpocetine for acute ischaemic stroke

    Bereczki D, Fekete I

    Published in Cochrane Database of Systematic Reviews

    Methodology

    Cochrane review of randomised trials of vinpocetine given within 14 days of acute ischaemic stroke.

    Key Findings

    Only two small trials with 70 participants were eligible; data on death and dependency were insufficient to estimate an effect.

    Conclusions

    There is not enough evidence to evaluate vinpocetine for acute ischaemic stroke.

    Limitations

    Very small evidence base and incomplete outcome reporting.

    Supplements Studied

    Vinpocetine
    Compound

    There is not enough evidence to evaluate the effect of vinpocetine on outcome after acute ischaemic stroke.

    Related Health Concerns

    Ischemic Stroke

    Study Details

    Year:2008
    Sample Size:70
    Duration:12 weeks
    Quality Score:9/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.